Evidence map›Paper›PMID 26678403›Full record

ArticleAIDS research and human retroviruses2016

The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.

Shambhu Prasad G Aralaguppe, Shilpee Sharma, Malini Menon, Vinayaka R Prasad, Shanmugam Saravanan, Kailapuri G Murugavel, Suniti Solomon, Udaykumar Ranga

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shambhu Prasad G Aralaguppe1 Molecular Biology and Genetics Unit, HIV-AIDS Laboratory, Jawaharlal Nehru Centre for Advanced Scientific Research , Bengaluru, India .
Shilpee Sharma1 Molecular Biology and Genetics Unit, HIV-AIDS Laboratory, Jawaharlal Nehru Centre for Advanced Scientific Research , Bengaluru, India .
Malini Menon1 Molecular Biology and Genetics Unit, HIV-AIDS Laboratory, Jawaharlal Nehru Centre for Advanced Scientific Research , Bengaluru, India .
Vinayaka R Prasad2 Department of Microbiology and Immunology, Albert Einstein College of Medicine , Bronx, New York, New York.
Shanmugam Saravanan3 YRG Centre for AIDS Research and Education , Chennai, India .
Kailapuri G Murugavel3 YRG Centre for AIDS Research and Education , Chennai, India .
Suniti Solomon3 YRG Centre for AIDS Research and Education , Chennai, India .
Udaykumar Ranga1 Molecular Biology and Genetics Unit, HIV-AIDS Laboratory, Jawaharlal Nehru Centre for Advanced Scientific Research , Bengaluru, India .

Funding

Dissecting the Role of HIV-1 Tat & Chemokine Axis in Subtype-Specificity of HADR01MH083579 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PRASAD, VINAYAKA R. · 2008 to 2012
$2.9M
NIMH NIH HHS R01 MH083579
6 · The paper itself

Abstract

Using several HIV-1 tat exon 1 amino acid sequences available from public databases and additional sequences derived from a southern Indian clinical cohort, we compared the profile of the signature amino acid residues (SAR) between two different time periods, 1986-2004 and 2005-2014. The analysis identified eight positions as signature residues in subtype C Tat and demonstrated a changing pattern at four of these positions between the two periods. At three locations (histidine 29, serine 57, and proline 60), there appears to be a nonuniform negative selection against the SAR. The negative selection appears to be severe, especially against histidine 29 (p < .0001) and moderate against proline 60 (p < .0001). The negative selection against serine 57 is statistically insignificant and appears to have begun recently. At position 63, the frequency of signature residue glutamic acid increased over the past decade, although the difference was not significant. Importantly, at the three locations where the negative selection is in progress, the substitute amino acids are the generic residues present in most of the other HIV-1 subtypes. Our data demonstrate that viral evolution can subject specific amino acid residues to subtle and progressive selection pressures without affecting the prevalence of other amino acid residues.

Indexed as

AdolescentAdultAmino Acid MotifsAmino Acid SequenceBase SequenceCross-Sectional StudiesFemaleHIV-1HIV InfectionsHumansIndiaMaleMiddle AgedSequence AlignmentSequence Analysis, DNAtat Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID26678403
PMCPMC5912721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.